Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Subtle Medical secures $33 million in Series C funding led by Morgan Stanley Expansion Capital to enhance medical imaging technology.

PRIVATEJun 02, 2026•2 months ago

Amount Raised

$33 Million

Round Type

Series C

Menlo Park

Investors

Samsung VenturesBrvEnvision XFusion FundShinhan Venture InvestmentMorgan Stanley Expansion Capital

Description

Subtle Medical has raised $33 million in growth capital through a Series C financing round led by Morgan Stanley Expansion Capital. The funds will accelerate product development and global commercial adoption of its AI-powered medical imaging platform. Notable participation also came from Shinhan Venture Investment and existing investors. The company aims to set a new standard for speed and quality in medical imaging.

Company Information

Company

Subtle Medical

Location

Menlo Park, California, United States

About

Subtle Medical, Inc. is a healthcare technology company with deep learning solutions that improve workflow efficiency and patient experience. The company has the first AI software solutions FDA-cleared for medical imaging enhancement, SubtlePET™ and SubtleMR™. It was named CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner.  Current clinical partners include UCSF, Hoag Hospital, Mt. Sinai, Sickkids, Radnet, DASA, Tiantan Hospital, and Middlesex Hospital, among others. Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, GE Healthcare, Philips (China) and several pharmaceutical partners. Subtle was founded in 2017.  Seed investors include Bessemer Venture Partners, Zhenfund (Momentor Ventures), Data Collective, Breyer Capital, and Baidu Ventures, among others. For more information, please visit subtlemedical.com or email [email protected].

Predictive Intelligence
Strategic

ML-powered predictions for Subtle Medical's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.